Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Overview and Rationale

Current Problems in Cancer

Volumn 33, Issue 3, 2009, Pages 125-141

  Shen, Perry ^a   Stewart IV, John H ^a   Levine, Edward A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BARIUM; DNA; GADOLINIUM; MITOMYCIN C;

APPENDIX CANCER; ARTICLE; ASCITES; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CAUSE OF DEATH; CHEMOSENSITIVITY; CHRONOTHERAPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DISSEMINATED CANCER; DNA DAMAGE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG INDICATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HEAT SENSITIVITY; HUMAN; HYPERTHERMIC THERAPY; INTRAOPERATIVE PERIOD; LIVER METASTASIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PATIENT SAFETY; PATIENT SELECTION; PERITONEAL DISEASE; PERITONEUM MESOTHELIOMA; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PROGNOSIS; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TEMPERATURE MEASUREMENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; PERITONEAL NEOPLASMS;

EID: 67651247126     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2009.06.003     Document Type: Article

References (63)

1. Pilati P., Rossi C.R., Mocellin S., Foletto M., Scagnet B., Pasetto L., and Lise M. Multimodal treatment of peritoneal carcinomatosis and sarcomatosis. Eur J Surg Oncol 27 (2001) 125-134
2. Sadeghi B., Arvieux C., Glehen O., Beaujard A.C., Rivoire M., Baulieux J., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 88 (2000) 358-363
3. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
4. Torisu M., Katano M., Kimura Y., Itoh H., and Takesue M. New approach to management of malignant ascites with a streptococcal preparation OK 432: Improvement of host immunity and prolongation of survival. Surgery 93 (1983) 357-3
5. Spratt J., Adcock M., Muskovin M., and Sherrill W. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 40 (1980) 256-260
6. Shen P., Levine E.A., Hall J., Case D., Russell G., and Fleming R. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 138 (2003) 26-33
7. Schwartz P.E., Rutherford T.J., Chambers J.T., Thiel E., and Kohorn R.P. Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival. Gynecol Oncol 72 (1999) 93-99
8. Levine E.A., Stewart J.H., Russell G.B., Geisinger K.R., Loggie B.L., and Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: Experience with 501 procedures. J Am Coll Surg 204 (2007) 943-953
9. Sugarbaker P.H. Peritoneal Carcinomatosis: Principles and Management. Boston, MA: Kluwer Academic (1996) 337-357
10. Simpson-Herren L., Sanford L., and Holmquist J.P. Effects of surgery on the cell kinetics of residual tumor. Cancer Treat Rep 60 (1976) 1749-1760
11. Gundaz N., Fisher B., and Saffer E.A. Effects of surgical removal on the growth and kinetics of residual tumor. Cancer Res 39 (1979) 3661-3865
12. Los G. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother Pharmacol 28 (1991) 159-165
13. Markman M. Intraperitoneal therapy in ovarian cancer utilizing agents achieving high local but low systemic exposures. Reg Cancer Treat 3 (1991) 264-268
14. Esquivel J., Vidal-Jove J., Steves M.A., and Sugarbaker P.H. Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 113 (1993) 631-636
15. Sugarbaker P.H., Zhu B.W., Sese G.B., and Shmookler B. Peritoneal carcinomatosis from appendiceal cancer: Results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 36 (1993) 323-329
16. Jacquet P., and Sugarbaker P. Abdominal adhesions causing intestinal obstruction following cytoreduction surgery and early postoperative intraperitoneal chemotherapy. Acta Chir Austriaca 27 (1995) 92-95
17. Jacquet P., and Sugarbaker P. Influence of wound healing on gastrointestinal cancer recurrence. Wounds 7 (1995) 1-8
18. Liakakos T., Thomakos N., Fine P.M., Dervenis C., and Young R.L. Peritoneal adhesions: Etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Digest Surg 18 (2001) 260-273
19. Raftery A.T. Regeneration of peritoneum: A fibrinolytic study. J Anat 129 (1979) 659-664
20. Markman M., Cleary S., Howell S.B., and Lucas W.E. Complications of extensive adhesion formation after intraperitoneal chemotherapy. Surg Gynecol Obstet 162 (1986) 445-448
21. Topuz E., Saip P., Aydiner A., Salihoglu Y., Aydin Y., and Topuzlu C. Catheter complications associated with intraperitoneal chemotherapy. Eur J Gynaecol Oncol 19 (1998) 275-279
22. Kodera Y., Yamamura Y., Shimizu Y., Torii A., Hirai T., Yasui K., et al. Peritoneal washing cytology: Prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 72 (1999) 60-64
23. Basha G., Ghirardi M., Geboes K., Yap S.H., and Penninckx F. Limitations of peritoneal lavage with antiseptics in prevention of recurrent colorectal cancer caused by tumor-cell seeding: Experimental study in rats. Dis Colon Rectum 43 (2000) 1713-1718
24. Sweitzer K.L., Nathanson S.D., Nelson L.T., and Zachary C. Irrigation does not dislodge or destroy tumor cells adherent to the tumor bed. J Surg Oncol 53 (1993) 184-190
25. Giovanella B.C., Stehlin J.S., and Morgan A.C. Selective lethal effect of supranormal temperature on human neoplastic cells. Cancer Res 36 (1976) 3944-3950
26. Dudar T.E., and Jain R.K. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 44 (1974) 605-612
27. Watanabe M., Tanaka R., Hondo H., and Kuroki M. Effects of antineoplastic agents and hyperthermia on cytotoxicity toward chronically hypoxic glioma cells. Int J Hyperthermia 8 (1992) 131-138
28. Teicher B.A., Kowal C.D., Kennedy K.A., and Sartorelli A.C. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 41 (1981) 1096-1099
29. Dawson L.E., Russell A.H., Tong D., and Wisbeck W.M. Adenocarcinoma of the sigmoid colon: Sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol 22 (1983) 95-99
30. Russell A.H., Tong D., Dawson L.E., Wisbeck W.M., Griffin T.W., Laramore G.E., and Luk K.H. Adenocarcinoma of the retroperitoneal ascending and descending colon: Sites of initial dissemination and clinical patterns of recurrence following surgery alone. Int J Radiat Oncol Biol Phys 9 (1983) 361-365
31. Sugarbaker P.H., and Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: Best palliation with a ray of hope for cure. Oncology 58 (2000) 96-107
32. Deraco M., Raspagliesi F., and Kusamura S. Management of peritoneal surface component of ovarian cancer. Surg Oncol Clin North Am 12 (2003) 561-583
33. McQuellon R.P., Loggie B.W., Fleming R.A., Russell G.B., Lehman A.B., and Rambo T.D. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 27 (2001) 65-73
34. McGuire W.P., Hoskins W.J., Brady M.F., Kucera P.R., Partridge E.E., Look K.Y., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334 (1996) 1-6
35. Moertel C.G. Peritoneal mesothelioma. Gastroenterology 63 (1972) 346-350
36. Chan P.S., Balfour T.W., Bourke J.B., and Smith P.G. Peritoneal mesothelioma. Br J Surg 62 (1975) 576-580
37. Brenner J., Sordillo P.P., Magill G.B., and Golbey R.B. Malignant peritoneal mesothelioma: Review of 25 patients. Am J Gastroenterol 75 (1981) 311-313
38. Antman K.H., Osteen R.T., Klegar K.L., Amato D.A., Pomfret E.A., Larson D.A., and Corson J.M. Early peritoneal mesothelioma: A treatable malignancy. Lancet 2 (1985) 977-981
39. de Bree E., Koops W., Kroger R., van Ruth S., Witkamp A.J., and Zoetmulder F.A. Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86 (2004) 64-73
40. Low R.N., Barone R.M., Lacey C., Sigeti J.S., Alzate G.D., and Sebrechts C.P. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204 (1997) 513-520
41. Sobhani I., Tiret E., Lebtahi R., Aparicio T., Itti E., Montravers F., et al. Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer 98 (2008) 875-880
42. Iwamoto A., Takahashi T., Sasabe T., Itoh M., Kondoh S., Seiki K., et al. Intraoperative chemotherapy with intraperitoneal activated carbon particles adsorbing mitomycin C against peritoneal dissemination of gastric cancer. Gan To Kagaku Ryoho 16 (1989) 2748-2751
43. Fujimoto S., Takahashi M., Mutou T., Kobayashi K., Toyosawa T., Isawa E., et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 79 (1997) 884-891
44. Ouchi K., Sugawara T., Ono H., Fujiya T., Kamiyama Y., Kakugawa Y., et al. Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69 (1998) 41-44
45. Hagiwara A., Togawa T., Yamasaki J., Ohgaki M., Imanishi T., Shirasu M., et al. Extensive gastrectomy and carbon-adsorbed mitomycin C for gastric cancer with peritoneal metastases. Case reports of survivors and their implications. Hepatogastroenterology 46 (1999) 1673-1677
46. Ronnett B.M., Zahn C.M., Kurman R.J., Kass M.E., Sugarbaker P.H., and Shmookler B.M. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei.". Am J Surg Pathol 19 (1995) 1390-1408
47. Gilly F.N., Carry P.Y., Sayag A.C., Brachet A., Panteix G., Salle B., et al. Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41 (1994) 124-129
48. Beaujard A.C., Glehen O., Caillot J.L., Francois Y., Bienvenu J., Panteix G., et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88 (2000) 2512-2519
49. Rey Y., Porcheron J., Talabard J.N., Szafnicki K., and Balique J.G. Peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemohyperthermia. Ann Chir 125 (2000) 631-642
50. Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6 (1999) 727-731
51. Look M., Chang D., and Sugarbaker P.H. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 14 (2004) 35-41
52. Sebbag G., Yan H., Shmookler B.M., Chang D., and Sugarbaker P.H. Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 87 (2000) 1587-1593
53. Kubik-Huch R.A., Dörffler W., von Schulthess G.K., Marincek B., Köchli O.R., Seifert B., et al. Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol 10 (2000) 761-767
54. Tentes A.A., Tripsiannis G., Markakidis S.K., Karanikiotis C.N., Tzegas G., Georgiadis G., and Avgidou K. Peritoneal cancer index: A prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol 29 (2003) 69-73
55. Berthet B., Sugarbaker T.A., Chang D., and Sugarbaker P.H. Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer 35 (1999) 413-419
56. Sebbag G., and Sugarbaker P.H. Peritoneal mesothelioma proposal for a staging system. Eur J Surg Oncol 27 (2001) 223-224
57. Shen P., Hawksworth J., Lovato J., Loggie B.W., Geisinger K.R., Fleming R.A., and Levine E.A. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 11 (2004) 178-186
58. Stewart J.H., Shen P., Russell G.B., Bradley R.F., Hundley J.C., Loggie B.L., et al. Appendiceal neoplasms with peritoneal dissemination: Outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 13 (2006) 624-634
59. Levine E.A., Stewart J.H., Russell G.B., Geisinger K.R., Loggie B.L., and Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: Experience with 501 procedures. J Am Coll Surg 204 (2007) 943-953
60. Glehen O., Kwiatkowski F., Sugarbaker P.H., Elias D., Levine E.A., De Simone M., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 22 (2004) 3284-3292
61. Glehen O., Cotte E., Kusamura S., Deraco M., Baratti D., Passot G., et al. Hyperthermic intraperitoneal chemotherapy: Nomenclature and modalities of perfusion. J Surg Oncol 98 (2008) 242-246
62. Ahmad S.A., Kim J., Sussman J.J., Soldano D.A., Pennington L.J., James L.E., and Lowy A.M. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion. Ann Surg Oncol 11 (2004) 387-392
63. Stephens A.D., Alderman R., Chang D., Edwards G.D., Esquivel J., Sebbag G., et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6 (1999) 790-796